The invention discloses a paediatric internal medicine center acute suppurative tonsillitis treating drug. The paediatric internal medicine center acute suppurative tonsillitis treating drug is mainlycomposed of raw materials including, by weight part, 8-14 parts of cefamandole, 14-17 parts of vicenin, 5-8 parts of physcion 8-O-beta-D-monoglucoside, 3-5 parts of 5-aminosalicylic acid, 16-27 partsof herba houttuyniae extract, 3-5 parts of coptis chinensis extract, 2-4 parts of hypoxanthine nucleotide, 6-8 parts of menthol, 5-10 parts of luteolin, 11-16 parts of baicalin, 1-8 parts of curzerene, 2-4 parts of borneol, 0.5-1.2 parts of verapamil and 1-5 parts of vitamin B. The paediatric internal medicine center acute suppurative tonsillitis treating drug achieves the aim of comprehensive rehabilitation, is rapid in effects on illness of patients, good and stable in therapeutic effects and convenient to carry and take, and can timely cure the diseases of the patients, avoid disease deterioration, minimize damage of tonsillitis to body of the patients, resist inflammation and relieve swelling and pain, reduce exudation of interstitial fluid and cell sap and promote tissue restoration.